INTROPIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Intropin, and when can generic versions of Intropin launch?
Intropin is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in INTROPIN is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Intropin
A generic version of INTROPIN was approved as dopamine hydrochloride by HOSPIRA on February 4th, 1982.
Summary for INTROPIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 235 |
Patent Applications: | 4,041 |
Formulation / Manufacturing: | see details |
DailyMed Link: | INTROPIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for INTROPIN
US Patents and Regulatory Information for INTROPIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | INTROPIN | dopamine hydrochloride | INJECTABLE;INJECTION | 017395-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | INTROPIN | dopamine hydrochloride | INJECTABLE;INJECTION | 017395-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | INTROPIN | dopamine hydrochloride | INJECTABLE;INJECTION | 017395-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |